Yu Z et al. found that bufalin inhibits the development of hepatitis B virus-associated hepatocellular carcinoma through AR dephosphorylation and cell cyclin-related kinase degradation (Yu et al., 2020). This evidence concerns the gene AR and hepatocellular carcinoma.